Nortriptyline Capsules manufacturers & suppliers

Nortriptyline Capsules

Form: Capsules

Strength: 10 mg, 25 mg, 50 mg, 75 mg

Reference Brands: Pamelor®(US); Nortrilen®(EU)

Category: Antipsychotropic Drugs

In the United States, nortriptyline capsules are FDA-approved for the treatment of major depressive disorder (MDD). As a tricyclic antidepressant (TCA), it carries a Boxed Warning about increased risk of suicidal ideation in children, adolescents, and young adults. Regulatory compliance includes GMP manufacturing, bioequivalence studies for generics, and post-marketing safety surveillance. In the European Union, nortriptyline capsules are approved via national regulatory pathways for depression and off-label uses like chronic pain. EU guidelines require a valid Risk Management Plan (RMP), pharmacovigilance reporting, and labelling aligned with EMA safety standards. For global sourcing and compliant supply, visit Pharmatradz.com.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details
Zuclopenthixol Short-Acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details
Zuclopenthixol Tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more